From Wikipedia,
the free encyclopedia
- The term
biopharmacology also
describes a field of research
closely related to
pharmacokinetics.
Biopharmaceuticals are
medical drugs (see
pharmacology) produced by
biotechnology. They are
actually
proteins or
nucleic acids (DNA
and
RNA) used for
therapeutic or
in vivo diagnostic
purposes, which is produced by
means other than direct
extraction from a native
(non-engineered)
biological source.
The first such substance
approved (1982) for therapeutic
use was recombinant human
insulin, (rHI, trade name
Humulin) developed by
Genentech and marketed by
Eli Lily.
Classification of
Biopharmaceuticals
Uses
Large scale production
Biopharmaceuticals may be
produced from microbial cells
(e.g.
recombinant E. coli),
mammalian cell lines (See
Cell culture) and plant cell
cultures (See
Plant tissue culture) in
bioreactors of various
configurations.
Important issues of concern are
cost of production (low volume
high purity product) and microbial
contamination (bacteria,
virus,
mycoplasma, etc). Alternative
platforms of production that are
being tested include whole plants
(Plant-made
pharmaceuticals).
See also
Reference